Illumina Unveils Promoterai, a Groundbreaking Algorithm to Accelerate Insights for Rare Disease Diagnosis

Illumina unveils PromoterAI - AI-Tech Park

New AI algorithm accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome at scale for the first time Illumina Inc. (NASDAQ: ILMN) today unveiled PromoterAI, a new AI algorithm that accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome. A study published today in Science illustrates how this deep learning technology discovered regulatory variants i…

Illumina Unveils Promoterai, a Groundbreaking Algorithm to Accelerate Insights for Rare Disease Diagnosis

Illumina Inc..today unveiled PromoterAI, a new AI algorithm that accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome. A study published today in Science illustrates how this deep learning technology discovered regulatory variants in noncoding “promoter” segments that contribute up to 6% of the genetic causes of rare diseases. By turning data into insights, this technology is expected to help r…